15 March 2017
As a result of the UK’s decision to leave the European Union (EU), we are working to assess the implications for medical research charities and patients and make sure our voice is heard in the debate about the UK’s future relations with the EU.
AMRC have developed a position statement on exiting the EU. Our position will be updated as policy developments unfold.
- As negotiations continue to determine the UK’s new relationship with the EU, it is vital that the deal reached ensures that there is no impact on patients, both within the UK and across the EU.
- Medical research charities view that a number of areas should be prioritised:
- The UK must be positioned as an attractive destination for global talent and expertise
- An aligned and compatible regulatory framework between the UK and the EU for medical research must be implemented
- Co-operation with EU regulatory frameworks and agreements for medicines and medical devices to ensure patients have timely access to new health innovations
- Continued participation in EU funding programmes and collaborative opportunities to progress the discovery and understanding of diseases and ill-health
- Ensuring no disruption in the supply and trade of medicines and other health technologies from day one of the UK’s new relationship with the EU.
Quality and standards
Data and impact
- We co-funded an evidence gathering project - The impact of collaboration: the value of UK medical research to EU science and health.
- We have made submissions on behalf of the sector to a number of inquiries and consultations including:
- Commons Science and Technology Committee inquiry on leaving the EU
- Scottish Parliament European and External Relations Committee inquiry on Scotland’s future relationship with the EU.